Daily Versus Thrice-Weekly Interferon Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in HIV-Infected Persons: A Multicenter Randomized Controlled Trial
2004 ◽
Vol 35
(5)
◽
pp. 464-472
◽
2004 ◽
Vol 99
(7)
◽
pp. 1298-1305
◽